Guided Therapeutics (GTHP) Return on Capital Employed Growth (5y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,918.00 |
| Sep 30, 2025 | 2,665.00 |
| Jun 30, 2025 | 2,981.00 |
| Mar 31, 2025 | 3,487.00 |
| Dec 31, 2024 | 3,552.00 |
| Sep 30, 2024 | 3,236.00 |
| Jun 30, 2024 | 3,757.00 |
| Mar 31, 2024 | 6,645.00 |
| Dec 31, 2023 | 9,925.00 |
| Sep 30, 2023 | 12,606.00 |
| Jun 30, 2023 | 17,087.00 |
| Mar 31, 2023 | 40,159.00 |
| Dec 31, 2022 | 23,860.00 |
| Sep 30, 2022 | 8,036.00 |
| Jun 30, 2022 | 1,956.00 |
| Mar 31, 2022 | 1,868.00 |
| Dec 31, 2021 | 1,012.00 |
| Sep 30, 2021 | 128.00 |
| Jun 30, 2021 | -4,349.00 |
| Mar 31, 2021 | -14,811.00 |
| Dec 31, 2020 | -21,488.00 |
| Sep 30, 2020 | -44,037.00 |
| Jun 30, 2020 | -50,102.00 |
| Mar 31, 2020 | -33,005.00 |
| Dec 31, 2019 | -69,885.00 |
| Sep 30, 2019 | -224,452.00 |
| Jun 30, 2019 | 103,064.00 |
| Mar 31, 2019 | 348,708.00 |
| Dec 31, 2018 | 50,337.00 |
| Sep 30, 2018 | 33,088.00 |
| Jun 30, 2018 | 26,699.00 |
| Mar 31, 2018 | 28,451.00 |
| Dec 31, 2017 | 26,843.00 |
| Sep 30, 2017 | 43,468.00 |
| Jun 30, 2017 | 349,560.00 |
| Mar 31, 2017 | 50,023.00 |